-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N6LgApvgSivsSqYXQYrcUyhI7OyLwlcDoB+jWoJ1S3magFTvAs3xbpoPr58Rkqgj ghaDMQ7C/8tcirB1o6Riwg== 0001144204-09-059725.txt : 20091116 0001144204-09-059725.hdr.sgml : 20091116 20091116154205 ACCESSION NUMBER: 0001144204-09-059725 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091116 FILED AS OF DATE: 20091116 DATE AS OF CHANGE: 20091116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLUSKIN ANNA E CENTRAL INDEX KEY: 0001125857 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 091186502 MAIL ADDRESS: STREET 1: 33 HARBOUR SQUARE STE 202 CITY: TORONTO STATE: A6 ZIP: M5H2G2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 4 1 v166684_ex.xml X0303 4 2009-11-16 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001125857 GLUSKIN ANNA E 33 HARBOUR SQUARE, SUITE 202 TORONTO A6 M5J 2G2 ONTARIO, CANADA 1 1 0 0 CEO & Pres. Common Stock 2019-11-16 4 P 0 10000 .51 A 226127 D Common Stock 953667 I By GHI, Inc. The reporting person may be deemed to beneficially own such 953,667 shares owned of record by GHI, Inc. by reason of the reporting person's ownership of investment power and other economic benefits associated with such shares. /s/ Anna E. Gluskin 2009-11-16 -----END PRIVACY-ENHANCED MESSAGE-----